Abstract
BackgroundInflammatory and metabolic biomarkers have been associated with hepatocellular cancer (HCC) risk in phases I and II biomarker studies. We developed and internally validated a robust metabolic biomarker panel predictive...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have